中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2026-09-302026-06-302026-03-312025-12-312025-09-30
营业总收入(万元)2440876.271545558.37814056.533162941.622318808.19
营业收入(万元)2440876.271545558.37814056.533162941.622318808.19
营业总成本(万元)1729449.581131314.04566732.242320389.331694966.54
营业成本(万元)322579.32211334.30109094.91436265.58319544.12
净利润(万元)687771.65443546.36227000.23772204.70577085.74
归属于母公司的净利润(万元)692340.42446543.94228226.82771105.48575116.95
营业利润(万元)799389.37508774.25260744.35899000.28662451.24
利润总额(万元)772862.99495241.75255686.21870762.55641200.78
少数股东损益(万元)-25.02-15.70-127.35594.74906.56
基本每股收益(元)1.05(元)0.68(元)0.34(元)1.19(元)0.89(元)
稀释每股收益(元)1.05(元)0.68(元)0.34(元)1.18(元)0.89(元)
非经常性损益(万元)----10986.9429764.9216181.98
扣除非经常性损益后净利润(万元)624316.23372958.90217239.88741340.56558934.97
总资产(万元)7671952.437077312.207129386.246986731.586832754.05
总负债(万元)938221.63578338.16714677.62807049.24829502.25
归属于母公司股东权益合计(万元)6681441.056446643.026362626.446127206.865950425.08
股东权益合计(万元)6733730.816498974.046414708.636179682.346003251.80
实收资本(股本)(万元)663719.99663719.99663719.99663719.99663719.99
资本公积(万元)1305336.801295582.671288296.761293461.631293203.73
未分配利润(万元)4577069.844331273.364245562.314017335.483834256.84
经营活动产生的现金流量净额(万元)784365.01198700.3978644.591123537.81911043.03
经营活动现金流入小计(万元)2630207.051435715.82692435.133483415.992697282.28
经营活动现金流出小计(万元)1845842.031237015.44613790.542359878.181786239.25
投资活动产生的现金流量净额(万元)-282778.48-182459.84-72374.60-274050.24-152626.69
投资活动现金流入小计(万元)15813.176820.691137.2922140.3918819.56
投资活动现金流出小计(万元)298591.64189280.5373511.90296190.63171446.25
筹资活动产生的现金流量净额(万元)-143654.66-158978.66-18571.70778170.74809102.04
筹资活动现金流入小计(万元)184467.61149109.5529953.421226567.911078027.32
筹资活动现金流出小计(万元)328122.27308088.2048525.12448397.17268925.28
期末现金及现金等价物余额(万元)4279513.263803152.493968283.414015555.273976770.81
最后修改日期2026-10-272026-08-192026-04-232026-03-272025-10-28
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。